Walter Buzina

Prof. Walter Buzina


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2013 in Medical Mycology
Verified
Journal Article
Open access
PDF file
LMLilian Masoud-Landgraf
Lilian Masoud-Landgraf
ABAlexandra Badura
Alexandra Badura
EEErnst Eber
Ernst Eber
GFGebhard Feierl
Gebhard Feierl
EMEgon Marth
Egon Marth
WBWalter Buzina
Walter Buzina
Cystic fibrosis (CF) is one of the most common genetic lung diseases worldwide. The production of sticky viscous mucus leads to enhanced bacterial co

13 September 2011 in Mycoses
Verified
Journal Article
Closed access
PDF file
RRReinhard B. Raggam
Reinhard B. Raggam
HSHelmut Salzer
Helmut Salzer
EMEgon Marth
Egon Marth
BHBettina Heiling
Bettina Heiling
Astrid Paulitsch-FuchsAstrid Paulitsch-Fuchs
Astrid Paulitsch-Fuchs
WBWalter Buzina
Walter Buzina

21 January 2013 in Mycoses
Verified
Journal Article
Closed access
PDF file
MHMartin Hoenigl
Martin Hoenigl
EAEngelbert Aspeck
Engelbert Aspeck
TVThomas Valentin
Thomas Valentin
BHBettina Heiling
Bettina Heiling
KSKatharina Seeber
Katharina Seeber
WBWalter Buzina
Walter Buzina

1 August 2018 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
SPShiva Pekard-Amenitsch
Shiva Pekard-Amenitsch
ASAgnes Schriebl
Agnes Schriebl
WPWilhelm Posawetz
Wilhelm Posawetz
BWBirgit Willinger
Birgit Willinger
BKBettina Kölli
Bettina Kölli
WBWalter Buzina
Walter Buzina
The emerging pathogen Candida auris is isolated mostly from hospitalized patients and often shows multidrug resistance. We report on the isolation of this yeast in Austria from an outpatient’s auditory canal. The isolate showed good susceptibility against antifungals except for echinocandins; the patient was treated successfully with topical administration of nystatin.

1 April 2013 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
WBWalter Buzina
Walter Buzina
Aspergillus is one of the most important fungal genera for the man, for its industrial use, its ability to spoil food and not least its medical impact as cause of a variety of diseases. Currently hundreds of species of Aspergillus are known; nearly fifty of them are able to cause infections in humans and animals. Recently, the genus Aspergillus is subdivided into 8 subgenera and 22 sections. The spectrum of diseases caused by Aspergillus species varies from superficial cutaneous to invasive and systemic infections. All species of Aspergillus investigated so far are resistant against the antifungals fluconazole and 5-fluorocytosine, the range of susceptibilities to currently available antifungals is discussed in this paper.

14 October 2011 in Mycoses
Verified
Journal Article
Open access
PDF file
SHSybren Sijbrand de Hoog
Sybren Sijbrand de Hoog
VRV. Robert
V. Robert
MLM. Lackner
M. Lackner
MVM. J. G. T. Vehreschild
M. J. G. T. Vehreschild
JVJ. J. Vehreschild
J. J. Vehreschild
RHR. Horré
R. Horré